Cargando…
Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence
COVID-19 is an infectious disease caused by a novel β-coronavirus, belonging to the same subgenus as the Severe Acute Respiratory Syndrome (SARS) virus. Remdesivir, an investigational broad-spectrum antiviral agent has previously demonstrated in vitro activity against Severe Acute Respiratory Syndro...
Autores principales: | Lin, Hui Xian Jaime, Cho, Sanda, Meyyur Aravamudan, Veeraraghavan, Sanda, Hnin Yu, Palraj, Raj, Molton, James S., Venkatachalam, Indumathi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778417/ https://www.ncbi.nlm.nih.gov/pubmed/33389708 http://dx.doi.org/10.1007/s15010-020-01557-7 |
Ejemplares similares
-
Metabolic associated fatty liver disease and COVID-19: a double whammy?
por: Lin, Jaime Hui Xian, et al.
Publicado: (2020) -
Gastrointestinal Symptoms in Association With Hypokalemia Can Be a Predictor of Inferior Outcomes in COVID-19
por: wong wai cheong, Nicholas, et al.
Publicado: (2021) -
Osteonecrosis of the Jaw and Concomitant Atypical Femoral Fractures with Bisphosphonates: A Comprehensive Literature Review
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2019) -
Clostridium difficile Infection in Liver Cirrhosis Carries a Higher Risk of Mortality: A Comprehensive Literature Review
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2019) -
Beyond the Liver, Hepatitis E Can Affect the Nerves, Pancreas, and Blood Vessels. Extrahepatic Manifestations of Hepatitis E: A Comprehensive Literature Review
por: Meyyur Aravamudan, Veeraraghavan, et al.
Publicado: (2019)